Novo and AgFunder both invested as the leather substitute producer raised $17m that will support the growth of its manufacturing capabilities.
US-based artificial leather developer MycoWorks has secured $17m in series A funding from investors including agricultural media and investment firm AgFunder and pharmaceutical firm Novo.
The round was led by DCVC Bio and also featured 8VC, Future Tech Labs, Susa Ventures, Cthulhu Ventures and Wireframe Ventures. It took place in 2019 but was officially announced this week.
MycoWorks has created a fine leather substitute called Reishi which is made from mycelium fungus. The cash will support the growth of its…
